Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barton

Showing results (201-210 of 297) with videos related to

Pageof 30
Sort By:
Rheumatology (Oxford, England)|June 30, 2020
Translating research into clinical practice: quality improvement to halve non-adherence to methotrexateAnne Barton, Meghna Jani, Christine Bundy, et al.
BMJ Open|June 21, 2024
10-year multimorbidity patterns among people with and without rheumatic and musculoskeletal diseases: an observational cohort study using linked electronic health records from Wales, UKFarideh Jalali-Najafabadi, Rowena Bailey, Jane Lyons, et al.
Rheumatology (Oxford, England)|April 4, 2022
Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapyMegan Sutcliffe, Nisha Nair, James Oliver, et al.
RMD Open|March 9, 2026
Inflammation response criteria for rheumatoid arthritis based on the two-component disease activity scoreMichael Stadler, Felice Rivellese, Darren Plant, et al.
Human Mutation|February 1, 2012
Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritisJames I Robinson, Ian M Carr, Dawn L Cooper, et al.
Annals of the Rheumatic Diseases|March 24, 2012
Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional studySarah L Mackie, John C Taylor, Sarah Twigg, et al.
Pharmaceutics|June 27, 2024
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid ArthritisStephanie F Ling, Kayode Ogungbenro, Adam S Darwich, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patientsLydia R Coulthard, John C Taylor, Steve Eyre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 30, 2023
Identification of Cell-Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid ArthritisCameron Adams, Nisha Nair, Darren Plant, et al.
Genetic Epidemiology|October 13, 2018
Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP dataSvetlana Cherlin, Darren Plant, John C Taylor, et al.
Pageof 30

Showing results (201-210 of 297) with videos related to

Sort By:
Pageof 30
Rheumatology (Oxford, England)|June 30, 2020
Translating research into clinical practice: quality improvement to halve non-adherence to methotrexateAnne Barton, Meghna Jani, Christine Bundy, et al.
BMJ Open|June 21, 2024
10-year multimorbidity patterns among people with and without rheumatic and musculoskeletal diseases: an observational cohort study using linked electronic health records from Wales, UKFarideh Jalali-Najafabadi, Rowena Bailey, Jane Lyons, et al.
Rheumatology (Oxford, England)|April 4, 2022
Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapyMegan Sutcliffe, Nisha Nair, James Oliver, et al.
RMD Open|March 9, 2026
Inflammation response criteria for rheumatoid arthritis based on the two-component disease activity scoreMichael Stadler, Felice Rivellese, Darren Plant, et al.
Human Mutation|February 1, 2012
Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritisJames I Robinson, Ian M Carr, Dawn L Cooper, et al.
Annals of the Rheumatic Diseases|March 24, 2012
Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional studySarah L Mackie, John C Taylor, Sarah Twigg, et al.
Pharmaceutics|June 27, 2024
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid ArthritisStephanie F Ling, Kayode Ogungbenro, Adam S Darwich, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patientsLydia R Coulthard, John C Taylor, Steve Eyre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 30, 2023
Identification of Cell-Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid ArthritisCameron Adams, Nisha Nair, Darren Plant, et al.
Genetic Epidemiology|October 13, 2018
Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP dataSvetlana Cherlin, Darren Plant, John C Taylor, et al.
Pageof 30